Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation - Jin, J; Wang, L; Wang, XK (J Surg Res, 2012)
Mar 31. [Epub ahead of print]